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The need for an Intersociety Consensus Guideline
for venous ulcer
Thomas F. O’Donnell Jr, MD, and Ethan M. Balk, MD, MPH, Boston, Mass
Background: The management of venous leg ulcers (VLU) consumes considerable resources in healthcare systems and
accounts for up to 1% of healthcare budgets in some industrialized countries. Best practice clinical guidelines incorporate
evidence-based diagnostic and therapeutic recommendations in a cost-effective manner and have been associated with
improved quality and less costly outcomes for many diseases. The objective of this study was to determine whether there
are common elements in guidelines for VLU and their evidentiary strength.
Methods:A systematic analysis of guidelines for VLU that were identified through http://clinicaltrials.gov, a government-
sponsored Web site, and other Web sites. The proportion of guidelines proposing a recommendation as well as the
strength of the guidelines were analyzed.
Results: Fourteen guidelines were identified, of which 13 were evidence-based, with the majority using the grading of
recommendations, assessment, development, and evaluation method. Five were sponsored by a government agency and
nine by a medical or nursing society, while nine had been developed or updated within the last 5 years. Ankle/brachial
index and venous duplex were recommended in 100% and 64%, respectively, of the guidelines. All recommended wound
dressings and high compression, with both at the strongly recommended level of 75% and 77%, respectively. Debridement
was suggested in 86%, but only one-third at the strong level. For adjunctive measures, 80% advocated pentoxifylline and
approximately 50% physical therapy for improving ankle joint mobility. The majority emphasized the preventive value of
compression stockings and surgical reduction of superficial venous hypertension, with a strong recommendation in 58%
in the former and 73% in the latter.
Conclusions:While there are numerous evidence-based guidelines for VLU, there is consensus on strong recommendations
for dressings and compression only among the various guidelines. A number of the guideline elements need further study
and refinement. To improve patient care and reduce wasted resources, it is imperative for specialty societies to collaborate
and develop this consensus document. (J Vasc Surg 2011;54:83S-90S.)
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gTrustworthy clinical practice guidelines present a syn-
thesis of evidence-based recommendations for the diagno-
sis and treatment of a specificmedical condition.1 The value
of a guideline is that it provides consistency among treat-
ment protocols given to patients, and as a result, both the
effectiveness and the quality of care should be improved.2
In addition, the cost of providing that care is usually
reduced. This latter factor has placed the development and
implementation of guidelines as a high priority for all
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doi:10.1016/j.jvs.2011.06.001ealthcare systems. An assortment of guidelines for the
ommon medical problem of venous leg ulcers (VLU) has
een developed, because of the major healthcare impact of
LU. This chronic disease is associated with a prevalence of
% to 1.5% of the population, a poor healing rate, and a
isappointingly high recurrence rate, exceeding 50%.3 As a
onsequence, the economic cost of treating VLU may
pproach 1% of the healthcare budget ofWestern countries;
n the United Kingdom, the annual cost is estimated to
ange from £300 to 600 million ($436 to $872 million
.S.) per year.4
There are numerous ways to treat VLU, whichmay vary
n efficacy, quality, and cost. An increasing number of
tudies have demonstrated that after the institution of a
LU guideline, however, there are improvements in both
lcer healing and recurrence rates, as well as a subsequent
owering of treatment costs.5,6,7 While several societies
ave developed VLU guidelines, there is little information
n the variability, utilization, and impact across these
uidelines. The Sixth Pacific Vascular Symposium, which
as sponsored by the American Venous Forum, had as its
oal the reduction of VLU by 50% over the next 10 years.
ne of the authors (TO) presented a survey at that meeting
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December Supplement 201184S O’Donnell and Balkcomparing the current use of VLU guidelines to the Amer-
ican College of Chest Physicians’ (ACCP) guideline for
prevention of the postthrombotic limb by five academic
health systems in the U.S. and representative single-payer
systems in Canada and Europe. Although two of five aca-
demic medical centers in the U.S. employed guidelines for
VLU, all but one in Canada and Europe used a VLU
guideline. By contrast, the ACCP guideline for prevention
of postthrombotic limb was almost universally employed in
the U.S., Canada, and Europe.8,9 Moreover, one of the
working groups at this meeting concluded that: (1) there
were too many guidelines on VLU from too many sources;
(2) “coordinated integration is difficult”; and most impor-
tantly, (3) there was a “need to unify evidence-based guide-
lines to facilitate implementation.”10
Based on these observations, it is the purpose of this
paper to: (1) assess currently available VLU guidelines for
their content, interguideline variability, and strength of
recommendations; (2) compare the recommendations
from the available guidelines to identify those with strong
recommendations; (3) consider the value of a constructing
a composite guideline; and (4) highlight areas of disagree-
ment or weak recommendations, which indicate the need
for further research.
METHODS
Analysis of specific guidelines. To find relevant
guidelines, we searched the National Guideline Clearing-
house (NGC; http://www.guidelines.gov), a Web site
maintained by the Agency for Healthcare Research and
Quality. The NGC provides a detailed template for each
guideline with the scope, methodology, recommendations,
evidence supporting their recommendations, benefits and
drawbacks of implementing the guideline recommenda-
tions, contraindications, qualifying statements, and imple-
mentation of the guideline. The NGC format also allows
determination of when and if the guideline was updated.
We also searched the Web sites for Clinical Evidence
(http://clinicalevidence.bmj.com) and the National Insti-
tute for Health and Clinical Excellence (http://www.nice.
org.uk); MEDLINE and Google, searching for “venous ul-
cer guidelines,” “leg ulcer guidelines,” and “best practices
for venous ulcer”; and a query of experts in Canada and
Europe about the existence of national VLU guidelines.
The searches were conducted up to December 20, 2010.
For inclusion, guidelines had to be available in English
(translation available) and be endorsed by either a govern-
ment agency or a professional society. We included all
currently available guidelines, regardless of age. Implicitly,
these guidelines have not been withdrawn by their devel-
opers and are available as putative current guidelines.
Guideline data were extracted by one author (TO) and
verified by the second (EB). Each guideline was reviewed
for methodology, whether evidenced-based, how evi-
dence was collected, method of assessing evidence, rat-
ing scheme for the strength of evidence, methods used to
formulate the recommendations as well as their strength,
and methods for guideline validation. The grading of cecommendations, assessment, development, and evalua-
ion (GRADE) method working group definitions were
mployed11: strength of recommendation—the extent to
hich one can be confident that adherence to the recom-
endation will do more good than harm; and strength of a
ody of evidence—the extent to which confidence in an
stimate of effect is sufficient to support a particular recom-
endation.
The guidelines were also defined by their target audi-
nce: primary care physicians, nurses, and specialists. The
pecific recommendations were broadly classified under:
1) diagnosis, including history and physical examination,
oppler assessment of the arterial circulation, and duplex
ssessment for venous reflux or occlusion; (2) wound care,
ncluding what elements of usual wound care were used
eg, cleansing, debridement),12 and type of wound dress-
ng, including nonocclusive, semiocclusive/occlusive, or
iological/human skin equivalent12; (3) compression type,
ncluding bandage, elastic stocking, or other, with specifics;
4) whether surgery was recommended (type and timing);
5) use of systemic treatment, such as pentoxifylline; (6)
revention, such as compression or surgery; and (7) grade
r strength of a specific recommendation.11 Since there
ere different methods of providing the level of recom-
endations, where both letters and numbers were used,
he following scale was used to connote the strength of the
uideline’s recommendation. However, not all guidelines
eported strengths for all recommendations.
evel Definition11
or I Strongly recommended to be of benefit
“We recommend”¡ Can be adopted as a policy
or II Recommended
or III Recommended, but not essential
or IV Not recommended
“Weak area for study or debate”
Concordance among recommendations. The three
actors associated with concordance or disagreement
mong the 14 guidelines were expressed as (1) the propor-
ion of a specific guideline elements described in the 14
uidelines; (2) the proportion with a strong recommenda-
ion for the element; and (3) the proportion with common
greement on how that recommendation should be
chieved. These were scored as Good agreement (75%-
00%), Fair agreement (50%-74%), and Poor agreement
50%).
ESULTS
uidelines in current use
We identified 14 VLU guidelines,13-26 of which the
ponsor was a specialty physician or nursing organization in
ine and a governmental agency in five (Table I). All but
wo guidelines were published or revised within the last 5
ears. The target audience of the guidelines was specified in
2 of the guidelines: physicians and nurses in seven; physi-
ians alone in five.
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Across the 14 guidelines, evidence was collected by
means of a systematic review in 13, four of which updated
the systematic reviews from previous guidelines and two
that used data from existing guidelines (Table I). The
strength or quality of evidence was detailed in eight of the
guidelines, and the strength of the recommendations was
provided in 13. Ten guidelines provided the method for
validating the recommendations, all using expert consensus
and/or peer review, supplemented by public comment in
one. Only six of the guidelines are available on the NGC
Web site.
Diagnosis of VLU
All 14 guidelines recommended a detailed history and
physical examination to eliminate other causes of lower ex-
tremity ulcers, such as arterial occlusive disease or rheumatoid
arthritis, but only three of 13 (that graded recommendations,
23%) as a strong recommendation. The guidelines uni-
formly recommended assessment of arterial perfusion by
Doppler ankle/brachial index (ABI), which was strongly
recommended in six (46%) and recommended or a weak
recommendation in seven guidelines (Table I). Several
guidelines stated that besides ruling out arterial disease, the
ABI value should influence not only the degree of compres-
sion (mmHg) provided by the garment, but also determine
whether the ulcer was a mixed arterial and venous ulcer in
etiology. Nine of 14 guidelines (64%) recommended du-
Table I. Characteristics of the 14 venous ulcer guidelines
Guideline
Year pu
(or upd
Norwegian Medicines Control Agency 1995
Royal New Zealand College of General Practitioners
Care of People with Chronic Leg Ulcers
1999
Registered Nurses’ Association of Ontario: NGC
005961a
2004, add
revision
Haute Autorite de Santea 2006
Royal College of Nursing 1998
Update 20
Canadian Association of Wound Care 2001
Update 20
Wound Care Society 2007
American Society of Plastic Surgeons: NGC 005966a 2007
German Society of Phlebology 2008
Wound Ostomy and Continence Nurses Society:
NGC 006521a
2008
Association for the Advancement of Wound Care:
NGC 006931
2008
National Practice and Evidence-based Guidelines of
Irelanda
2009
Scottish Intercollegiate Guidelines Networka,b 2009
American Venous Forum 2009
GP, General practice physicians; HCP, healthcare providers; MD, all physic
aOn National Guidelines Clearinghouse Web site.
bUsed existing Scottish Intercollegiate Guidelines Network and Royal Colleplex assessment for venous disease, as manifested by reflux, eut less than half at a strong recommendation level. Thir-
een guidelines suggested measurements of the ulcer size,
lthough the minority (4/12, 25%) at a strong recommen-
ation level. The guidelines recommended against routine
ulture of the ulcer, so that culture (preferably quantitative)
hould be employed only when there was evidence of active
nfection. All guidelines suggested that cleansing the
ound with tap water prior to treatment was sufficient.
ebridement was discussed extensively with a clear definition
fwhen to employ either chemical or surgical debridement for
he ulcer. The strength of recommendation, however, for
oth cleansing and debridement of the wound was at the
trong level in approximately one-third of guidelines.
reatment of venous leg ulcer
Wound dressings. Wound dressings were classified
nto nonocclusive (simple nonadhering), semiocclusive/
cclusive, and advanced (either growth factor or human
ermal equivalent).12 All but three recommendations for
ressings were graded at the strong recommendation level
Table II). Although 11 guidelines favored a “moist wound
nvironment,” five suggested a simple nonadherent dress-
ng with a strong recommendation and cited the Cochrane
ystematic Analysis of wound dressings, which preceded
he guideline, as support. Three guidelines stated that the
ype of wound dressing employed should depend on the
haracter of the wound. Hydrocolloid was recommended
or wounds with granulating bases in two, while in highly
d
) Source Funding Target
Government MD
Government, society None GP/nurses
m/ Society Government Nurses
Government Government MD
Government, society Nurses
Society MD
Society MD
Society Society Specialist
Society Society HCP
Specialist
Society Not reported Nurses/HCP
Society Industry,
government
Nurses/HCP
Government Government MD
Government Government Nurses/specialists
Society Society Specialists
Nursing systematic reviews.blishe
ated
endu
2007
06
06
ians.xudative wounds, alginate was preferred. Advanced skin
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December Supplement 201186S O’Donnell and Balkdressings were recommended only rarely and restricted to
“hard to heal” ulcers.
Compression. All guidelines recommended high com-
pression garments, nine at the strongly recommended
level.27 Seven did not specify the type of “high compres-
sion,” but four guidelines advocated four-layer bandages
and three short stretch garments. Again, the latest Co-
chrane report was used as evidence for this recommenda-
tion. Some guidelines expanded the choice of compression
garment, which delivered the high compression, to elastic
stockings or Unna’s boot.
Adjunctive measures. Skin grafts were recommended
for ulcers that failed to heal in a timely manner in 10
guidelines with one-half as a strong recommendation.
Eleven guidelines suggested the use of pentoxyfilline, with
two-thirds at a strong level. Only half the guidelines em-
phasized the role of physical therapy in improving and
maintaining ankle joint mobility to facilitate calf muscle
pump function.
Prevention. All but one guideline recommended
below-knee 20/30-mm Hg compression stockings to
prevent ulcer recurrence with a strong grade of recom-
mendation in seven. In addition, 11 guidelines recom-
mended surgical treatment of superficial venous hyper-
tension. The long-term results of compression therapy
alone versus compression plus surgery in chronic venous
ulceration (ESCHAR) trial was cited as compelling evi-
Table I. Continued
Method to collect evidence
Evidence rating
system Recommenda
Not reported None None
Systematic reviewb I¡ IV A-C
Systematic review, previous
guideline
None A-C
Systematic review None A-C
Systematic review, previous
guideline
I-III Endorsement
Systematic review None A-C
Systematic review, previous
guideline
? I-III
Systematic review, previous
guideline
I-V A-D
Systematic review ?? Type A-C
Systematic review I-VI A-C
Systematic review ? A-C
Systematic review, other
guidelines
1-3 A-CD
Systematic review 1-4 A-D
Systematic review 1-4 A-Ddence for the efficacy of saphenous ablation to prevent cLU recurrence in many guidelines,28 but older guidelines
ncluded treatment of perforator incompetence at a weak
ecommendation level.
oncordance/disagreement among guidelines
Table III summarizes the three factors associated with
oncordance or disagreement among the 14 guidelines.
he majority of guidelines (11/14, 78%) recommended
he available specific guideline elements. By contrast, the
roportion with a strong recommendation for specific ele-
ents was quite low (3/13; 23%), but was at the strongest
ecommendation level (A  75%) for wound dressings,
ompression, and the prevention of recurrence by surgery.
ecommendations for various methods of diagnosis uni-
ormly received a low proportion of strong recommenda-
ions, as did various aspects of wound care. Finally, the
roportion with common agreement on how that recom-
endation should be achieved was dependent on the na-
ure of the specific recommendation. Wound dressings,
ompression, skin grafts, and surgery to prevent recurrence
xhibited the greatest variability as described in the preced-
ng sections on that individual guideline element.
ISCUSSION
The Institute of Medicine has defined guidelines as
Systematically developed statements to assist practitioner
nd patient decisions about appropriate healthcare for spe-
rength system
Recommendation formulation
method
Guideline
validation
Not reported Not reported
Multidisciplinary expert
consensus
Group
Expert consensus Agree
Peer review None
(“strongly”) NS None
NS NS
Peer review None
Expert consensus None
Expert consensus None
Expert consensus None
Expert consensus None
Expert consensus None
Expert consensus, public
input
None
Peer review Nonetion st
levelific clinical circumstances.”1 Guidelines should decrease
d
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Volume 54, Number 19S O’Donnell and Balk 87Svariations in care, improve quality of care, optimize re-
source use, and subsequently reduce the cost of care. Our
previous survey, however, demonstrated that guidelines for
VLU care are infrequently used in the U.S., but are com-
monly used in countries with single-payer healthcare sys-
tems.8,9 This low utilization in the U.S. occurred despite
the availability of four guidelines developed in the U.S. by
specialties. Moreover, these guidelines provide up-to-date
recommendations for VLU care with general agreement on
Table II. Summary of guideline-specific elements reported
Specific guideline element
Inclusion of guid
No. (%) (n
Diagnosis
Clinical examination 14 (10
Doppler ankle/brachial index 14 (10
Duplex 9 (64
Wound care
Measure size 13 (93
Cultureb 11 (79
Cleanse 13 (93
Debride 12 (86
Dressing 14 (10
Compression 14 (10
Adjunctive treatment
Skin graft 10 (71
Pentoxifylline 11 (79
Physical therapy¡ ankle mobility 8 (58
Prevention
Below-the-knee stockings 13 (93
Surgery 11 (79
Percent  Number of guidelines citing this strength/number of guidelines
N.B. Norwegian Guideline13 did not report strength, and not all guidelines
aNumber of guidelines citing the strength of the recommendation.
bRecommended against routine culture.
Table III. Degree of agreement across guidelines
Specific guideline element
Inclusion
guideline elem
Diagnosis
Clinical examination Good
Doppler ankle/brachial index Good
Duplex Fair
Wound care
Measure size Good
Culture Good
Cleanse Good
Debridement Good
Dressing Good
Compression Good
Adjunctive treatment
Skin graft Fair
Pentoxifylline Good
Physical therapy¡ ankle
mobility
Fair
Prevention
Below-the-knee stockings Good
Surgery Good
N.B. Norwegian Guideline13 did not report strength and not all guidelines
aGood, 75% to 100% agreement; Fair, 50% to 74% agreement; Poor, 50%the type and strength of recommendations for the essential riagnostic and therapeutic elements. However, there is a
lethora of overlapping guidelines for the management
f venous ulcers, with varying degrees of agreement
mong the individual recommendations and the contin-
ed implied currency of several older guidelines. A con-
ensus guideline would be of value to reduce the redun-
ancy of the multiple guidelines, to achieve a single
onsensus, to enhance the trustworthiness of the guide-
ine, and to reduce the problem of potentially outdated
strength of recommendation
lement
)
Strong
recommendationa Recommendeda
3 (23) 4 (31)
6 (46) 4 (31)
4 (44) 2 (22)
3 (25) 4 (33)
1 (10) 8 (80)
3 (25) 4 (33)
4 (36) 3 (27)
10 (77) 2 (15)
9 (75) 3 (23)
5 (56) 4 (44)
7 (64) 2 (18)
4 (50) 0
7 (58) 2 (18)
8 (73) 1 (9)
ting the strength of recommendation.
ded the strength of the recommendation.
Recommendation
strengtha
Agreement on
type
Poor Consensus
Poor Consensus
Poor Consensus
Poor Consensus
Poor Consensus
Poor Consensus
Poor No consensus
Good No consensus
Good No consensus
Fair No consensus
Fair Consensus
Fair Consensus
Fair Consensus
Good No consensus
ed the strengths of the recommendations.
ment.and
eline e
 14
0)
0)
)
)
)
)
)
0)
0)
)
)
)
)
)
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entaecommendations.29
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December Supplement 201188S O’Donnell and BalkDevelopment of guidelines for venous ulcers. Of
the 14 guidelines reviewed, there was broad agreement on
the general diagnostic and therapeutic recommendations
for VLU, as indicated by the inclusion of specific recom-
mendations among the 14 sets of guidelines (Tables II and
III). The strength of these recommendations, however,
varied across guidelines. The concordance of recommenda-
tions for VLU in certain areas should facilitate the potential
development of a more universal basic set of guidelines for
VLU, and the lack of concordance point out areas to be
researched further and/or refined (Table III).
Guidelines are part of an evidence-based approach to
implementing best practices for the diagnosis and manage-
ment of VLU and are intended to decrease the inherent
variations in treating this problem. Ideally, guidelines should
combine a rigorous systematic review of the strength of evi-
dence for efficacy supplemented by the opinions of experts.2
These clinical care guidelines should transfer new methods,
techniques, and devices/products that have been validated
by properly conducted randomized controlled trials. In
addition, these protocols should aim to provide the best
quality of care without a significant increase in cost. This
focus on “best outcomes for themost reasonable healthcare
dollar”29 has stimulated many organizations and govern-
mental healthcare agencies to develop and promote a uni-
fied set of guidelines for treating chronic diseases, but not
yet for VLU. Moreover, an evidence-based analysis of
treatment options should decrease the variations in care,
while at the same time ensure that resources are used in an
optimal manner.1 The value of care guidelines is that they
sift through a massive amount of data surrounding the
treatment of a condition and provide a consensus on the
evidence for treatment of that disease.2
To provide a consistent framework for composing
guidelines, the GRADE group has developed a system for
evaluating the quality of the evidence as well as the strength
of recommendations.11 The proliferation of guidelines,
some of which offered conflicting recommendations, initi-
ated the GRADE system for judging the quality of evidence.
Using theGRADE system, the guideline committees rates the
quality of recommendations based on four critical and inter-
linked factors: (1) study design; (2) study quality; (3) con-
sistency of evidence; and (4) directness. The strength of
each recommendation is based on the balance between the
benefit to harm of that recommendation.
There are obvious advantages to the development and
use of guidelines, but such “best practices” can be con-
strued as antithetical to the autonomy of clinical practitio-
ners, who make decisions based on individual patients.
These factors may prevent total buy-in by physicians.More-
over, a set of guidelines can be interpreted as instituting the
rigid perspectives of policymakers on healthcare delivery for
a specific disease process.8,9 Finally, guidelines have to be
constantly monitored in order to guarantee that they keep
pace with new techniques. However, since trustworthy,
high-quality guidelines are developed through a delibera-
tive evidence-based process involving physician experts, burses, and, most recently, patients, and are constantly
pdated, the previous criticisms are less tenable.1
Efficacy of current guidelines for venous leg ulcer.
here are several studies that have assessed the impact of
mplementing individual recommendations from VLU
uidelines. Olson and associates demonstrated that ulcer
ealing rate was markedly improved in a Veterans Hospital
opulation of 155 patients, if certain recommendations
rom a VLU guideline were followed.5 Over a 5-year pe-
iod, patients who received dressings that provided a moist
ound healing environment and compression for 80% of
heir visits were more likely to heal than those that did not
omply (relative risk [RR], 2.52; 95% confidence interval
CI], 1.53-4.16). In a combined study population of pa-
ients from the U.K. and the U.S., patients who were
reated for VLU under a guideline had, respectively, a 2-
nd a 6.5-times greater likelihood of healing if the guide-
ines were followed (P .01).7Moreover, the median costs
ere reduced with adherence to VLU recommendations
P  .01). To compare usual care with care recommended
y theNewZealand VLU guidelines, 181 patients from the
oney as Adjuvant Leg Ulcer Therapy (HALT) trial were
ssessed for their adherence to four recommendations.30
very patient received compression, but only 29% of pa-
ients received simple dressings. Following healing of the
LU, 70% of the patients wore compression. Also, in the
ongitudinal Skaraborg County, Sweden study, general
opulation participants were assessed clinically and with
idirectional Doppler ultrasound for a baseline point prev-
lence of VLU of 0.3%. Furthermore, this study underlined
he importance of Doppler evaluation, because one of four
atients would bemisdiagnosed on clinical grounds alone.6
fter institution of guidelines for VLU (Norwegian/Swedish
uidelines: Table I), which emphasized early color duplex
ltrasound-aided diagnosis with surgery for superficial ve-
ous incompetence, the point prevalence decreased by 20%
o 67% in different subgroups of people from 1990 to
005, largely due to a reduction in recurrence.
Consensus guidelines. Vascular surgeons should be
amiliar with the consensus process for developing a “syn-
hesized common” guideline that addresses vascular dis-
ase. In 2000, the Trans-Atlantic Inter-Society Consensus
ocument on Management of Peripheral Arterial Disease
TASC), brought together 14 vascular, cardiovascular, inter-
entional radiology, and cardiology societies from Europe
nd North America, later expanded to 16 societies, to
roduce consensus documents that provided guidelines on
he diagnosis and management of arterial disease (TASC I
nd II).31,32 The process involved bringing the recommen-
ations back to the participating societies for comment and
ndorsement. The TASC documents not only provided a
niform classification system for the anatomical extent of
rterial disease, but also a consensus on the best treatment
lan. Furthermore, the systematic review pointed out areas
or future improvements in therapy. Unlike the classifica-
ion of arterial disease by TASC, with the exception of the
merican Venous Forum and the German Society for Phle-
ology, no VLU guideline recommended a method for
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Volume 54, Number 19S O’Donnell and Balk 89Sclassifying venous ulcers as to their cause and anatomy, such
as the CEAP classification system. Inclusion of CEAP is
essential for classifying the baseline characteristics of VLU
patients.
A second example is from a single society’s sponsor-
ship (the ACCP) of a landmark set of guidelines for the
diagnosis and treatment of thromboembolic disease.33
Their evidence-based method of assessing the level of evi-
dence and the strength of recommendation has become the
hallmark for most vascular guidelines, but they did leave
room for independent clinical input: “Although the recom-
mendations are evidence-based, we also provide sugges-
tions that clinicians might find useful when the evidence is
weak.”33 These two methods for developing consensus
guidelines for vascular disease provide templates for various
societies and governmental agencies to collaborate on de-
veloping a similar set of guidelines for VLU.
Areas of disagreement requiring further study. The
existing VLU guidelines can provide a road map for a
consensus document as well as pointing out areas of dis-
agreement that will require further research and discussion.
Three factors determine consensus or, alternatively, dis-
agreement: (1) inclusion of a specific guideline element in
the majority of guidelines; (2) proportion with a strong
recommendation for that element; and (3) common agree-
ment on how that recommendation should be achieved
(eg, dressing type). Moreover, the target audience for the
guidelines will influence these three factors. Specialists might
be more likely to use duplex (included in 9/14 [64%] of the
guidelines) to refine the diagnosis and guide therapy (super-
ficial/deep system involvement, postthrombotic changes)
than primary care physicians or nurses. The Swedish study,
however, showed the importance of identifying superficial
incompetence and its correction on reducing the incidence
of ulcer. Although most of the guidelines included diag-
nostic, wound care, and adjunctive elements (Table III –
Good agreement), relatively few guidelines included the
adjunctive therapy measures of skin grafts (71%) and phys-
ical therapy (58%) to improve the calf-muscle pump. Our
analysis showed that for the following specific elements,
strong recommendations predominated: compression
(75%), dressings (77%), and surgery (73%), while adjunc-
tive treatment with pentoxyfilline (64%) and preventive
measures such as below-knee stockings (58%) were rated as
fair. By contrast, several elements, although recommended
in many of the 14 guidelines, had weak strength of recom-
mendation grades and will require further analysis and
discussion before incorporating them into a set of common
guidelines. These elements include clinical examination,
Doppler ABI, and duplex scanning for diagnosis; measure-
ment of wound size, condition of the wound, wound
cleansing, and debridement; and use of adjunctive mea-
sures, such as skin grafts; and physical therapy. Many of
these elements involve treatment at the “specialist level,”
and the development of these elements will need to involve
these physicians. Although wound dressings and compres-
sion were a specific element in all 14 guidelines and received
“strong” recommendations (fair 75%), there was lack ofgreement about: (1) the type of wound dressing – simple
onadherent (usually not well specified) versus varying the
ressing type with the condition of the ulcer and (2) the
orm of “high compression” – four-layer elastic stretch
ersus short stretch inelastic versus Unna’s boot.
In addition, several areas of “controversy,” which were
ot thoroughly discussed, need to be examined, including
he role of iliac vein obstruction and its correction with the
eed for intravascular ultrasound and stenting34; treatment
f perforators35; specialized wound dressings such as anti-
icrobials like cadexomer iodide or silver-based dress-
ngs36; and other advanced dressings such as dermal substi-
utes and skin grafts.37
Integrated delivery of healthcare. An additional
opic that should be considered in a consensus VLU guide-
ine is the role of an integrated delivery of treatment. One
odel to achieve an integration of venous ulcer care is
hrough an integrated health care system, which is defined
s a complex of facilities, organizations, and trained person-
el engaged in providing health care within a geographic
rea.38 In the treatment of chronic diseases, such as venous
lcers, health care systems rely heavily on nursing personnel
nd other health care workers for the delivery of services.
are of patients with VLU is shifted toward the home or
ursing home facility, and when combined with experi-
nced wound care nurses managing the patient, hospital
nd clinic visits are reduced, as are indirect costs (eg, lost
ime from work).
ONCLUSIONS
This review of 14 existing guidelines for the diagnosis
nd management of venous ulcer demonstrates concor-
ance on the need for compression and wound dressings as
ell as preventive measures. Further analysis of the evi-
ence for establishing the diagnosis of venous ulcers,
ound management, and ancillary procedures is needed.
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